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Today, the Coronavirus (2019-nCoV) pandemic is considered a
great threat to the global health, and numerous deaths are attrib-
uted to this deadly virus all across the world during the last
months. Morbidity and mortality have been reported all across
the world during the last two months [1]. As documented in
details elsewhere, everybody is susceptible to this newly-
emerged coronavirus, but people with underlying conditions
such as hypertension and diabetes are more apt to develop
serious and life-threatening complications [2]. Although people
with osteoporosis and those taking osteoporosis medications
are neither at a greater risk for contracting the disease nor more
susceptible to develop serious complications, prevention from
osteoporotic fractures in the present situation is of utmost im-
portance [3]. However, seeking medical attentions including
treatment and monitoring services by osteoporotic patients
makes them at a higher risk for the infection. As a matter of
fact, in today’s resource-constrained health systems both in
developing and developed world, placing extra burden on
health systems is quite irresponsible. Moreover patients with
osteoporosis and diabetes can exponentially increase their risk
of contracting the disease by exposing themselves to hospitals
and other healthcare facilities. This can be potentially remedied
through promoting usage of digital health technology, and
patients with osteoporosis and diabetes should be encouraged
to use telehealth services as far as they can, and avoid exposing
themselves to the high-risk clinical environments [4].
Iran is, unfortunately, among the countries with the higher
numbers of both contracted and diseased corona virus cases
both in the globe and the Middle East [5]. Endocrinology and
Metabolism Research Institute (EMRI) of Tehran University
of Medical Sciences (TUMS) has been assigned as a World
Health Organization (WHO) Collaborating Centre for re-
search and education on management of diabetes and osteo-
porosis since 2007, and this collaboration continued until
2019 [6]. In such capacity, EMRI regularly designs and carries
out different national and international events with the objec-
tive of promoting the knowledge and skills of Iranian clini-
cians and scientists about latest advances in the field of endo-
crinology and metabolic diseases. Many of these educational
events and sessions are designed and implemented under di-
rect supervision of globally-renowned organizations such as
WHO (World Health Organization) and IOF (International
Osteoporosis Federation).
During the past few months, in collaboration with other
domestic and international organizations concerned, scientist
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pandemic developments as they unfold with the main objec-
tive of delivering the best possible prevention and manage-
ment service to people with diabetes and osteoporosis. These
activities include design and publication of treatment proto-
cols as well as professional and public educational materials
(books, booklets, videos) in Persian language. All published
materials are freely accessible to all Iranian and Persian-
speaking patients and clinicians all across the world.
In the early beginnings of the outbreak, EMRI published a
booklet entitled “Diabetes Management during the Sick
Days” which aimed at easing psychological burden imposed
on patients with diabetes and their caregivers. This publication
is freely available on the official website of the Institute.
Moreover, simultaneously, an educational video clip in
Persian language entitled “Diabetes Management in
Coronavirus”was produced and published on EMRI website.
Initially, with the view of development a robust infrastruc-
ture, Iranian Diabetes Academy (IDA) [7] was formed as a
platform for production and dissemination of valid and cred-
ible information about diabetes and its complications for both
healthcare providers and patient through e-learning technolo-
gy. Addressing the current epidemics, an instruction pamphlet
for patients with diabetes and their caregivers entitled
“COVID-19 Outbreak: Guidance for People with Diabetes”
was published. Moreover, based on the information provided
by the International Diabetes Federation (IDF), a booklet en-
titled “Professional Guideline for Management of Patients
with Diabetes during the Coronavirus Pandemic” was
adapted for the use of Iranian health care providers and made
accessible for all interested individuals and organizations. It is
noteworthy, moreover, that there are several CMEmodules in
Persian about diabetesmanagement on the IDAwebsite which
can be of immense benefit to health care providers. All inter-
ested individuals can freely access these online modules and
promote their knowledge and skills about diabetes manage-
ment during the current pandemic.
Similarly, International Osteoporosis Foundation (IOF) has
published a set of general recommendations for people with
osteoporosis entitled “COVID-19 and Osteoporosis” to en-
courage patients to continue taking medications and avoid
fracture risks. Also, IOF has produced and informative mate-
rial entitled “Delays to Medication” which aims to inform
patients about continuation or modification of the medicine
they currently use. Likewise, the other material of IOF
about “Vitamin D and coronavirus”was translated to provide
applied information about taking Vitamin D supplements and
sunlight during stay home. All aforementioned materials were
translated in Persian and uploaded on the official website of
the EMRI, and this invaluable information is all accessible
free of charge. Moreover, EMRI is working to develop an
online course for education of health care professionals on
the management of osteoporosis during the pandemic period.
Concerning to the WHO global strategy on digital health,
the success of the digital transformation of the health-care
sector requires all stakeholders to think of new ways to con-
tribute to conquering national and global health goals.
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